Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 00:41 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer
NCT00019695 · National Cancer Institute (NCI) · PHASE2 · terminated · last registry update 2024-03-04 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
No reason was published
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | The registry record gives no reason | – | Registry record, National Cancer Institute (NCI) |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against FDPS within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2024-12-13Results posted on the registry: University Hospital, Ghent, Alendronate Effervescent Oral Tablet (NCT04403698)
- 2024-08-29Results posted on the registry: University of Nebraska, Zoledronic Acid 5 mg/Bag 100 ml Inj + Placebos (NCT04279392)
- 2024-08-13Results posted on the registry: Wuerzburg University Hospital, Aclasta + Placebo (NCT01348269)
- 2024-08-01Phase 3 first posted: Massachusetts General Hospital, Romosozumab + Placebo (NCT06533865)
- 2024-05-08Results posted on the registry: Columbia University, Alendronate + Zoledronic Acid (NCT03396315)
- 2024-03-15Results posted on the registry: Austrian Breast & Colorectal Cancer Study Group, tamoxifen + anastrozole (NCT00295646)
- 2024-02-20Results posted on the registry: Masonic Cancer Center, University of Minnesota, Pamidronate + Calcium and vitamin D (NCT02074631)
- 2024-01-24Phase 3 first posted: Shanghai JMT-Bio Inc., JMT103 + zoledronic acid (NCT06221072)
- 2023-10-12Results posted on the registry: Massachusetts General Hospital, Testosterone + Alendronate (NCT01460654)
- 2023-10-12Also stopped (terminated): Massachusetts General Hospital, Testosterone + Alendronate (NCT01460654)
- 2023-08-22Results posted on the registry: University of New Mexico, pamidronate (NCT00655681)
- 2023-08-16Results posted on the registry: Susan L. Greenspan, Zoledronic acid (NCT02589600)
- 2023-07-14Results posted on the registry: Wake Forest University Health Sciences, risedronate + Matching placebo (NCT03861091)
- 2023-06-27Results posted on the registry: University of Nebraska, Calcium Carbonate + Vitamin D3 (NCT02186600)
- 2023-05-23Results posted on the registry: Thomas Jefferson University, Zoledronic acid + normal saline 0.9% (NCT01642901)
- 2023-05-19Phase 3 first posted: Sun Yat-sen University, Zoledronic acid (NCT05866172)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision